SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001387131-22-006345
Filing Date
2022-05-23
Accepted
2022-05-23 08:00:47
Documents
10
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 DEFINIITVE PROXY STATEMENT cagm-def14a_063022.htm DEF 14A 1757245
2 GRAPHIC cagm-def14a_063022img001.gif GRAPHIC 94326
3 GRAPHIC cagm-def14a_063022img002.gif GRAPHIC 176001
4 GRAPHIC cagm-def14a_063022img003.gif GRAPHIC 131396
5 GRAPHIC cagm-def14a_063022img004.gif GRAPHIC 13882
6 GRAPHIC proxycard001.jpg GRAPHIC 1395
7 GRAPHIC proxycard002.jpg GRAPHIC 629
8 GRAPHIC proxycard003.jpg GRAPHIC 3116
9 GRAPHIC proxycard004.jpg GRAPHIC 4550
10 GRAPHIC proxycard005.jpg GRAPHIC 5702
  Complete submission text file 0001387131-22-006345.txt   2353079
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40445 | Film No.: 22949615
SIC: 2834 Pharmaceutical Preparations